Baird Maintains Neutral on Molina Healthcare, Raises Price Target to $163
Benzinga Newsdesk 6 months ago
NewsPrice TargetAnalyst Ratings
Baird analyst Michael Ha maintains Molina Healthcare (NYSE:MOH) with a Neutral and raises the price target from $124 to $163.
Baird analyst Michael Ha maintains Molina Healthcare (NYSE:MOH) with a Neutral and raises the price target from $124 to $163.